BMS 6070 850
Generic Name: metformin
Pill imprint BMS 6070 850 has been identified as Glucophage 850 mg.
Glucophage is used in the treatment of diabetes, type 2; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Glucophage 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Glucophage Images
- Generic Name:
- metformin
- Imprint:
-
BMS 6070
850 - Strength:
- 850 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- povidone
magnesium stearate
hypromellose
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6070
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3546 | Physicians Total Care Inc (repackager) |
| 54569-4740 | A S Medication Solutions LLC (repackager) |
| 58016-0457 | Southwood Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glucophage resources
- Glucophage
- Glucophage (Wolters Kluwer)
- Glucophage (Cerner Multum)
- Glucophage (Micromedex) - Includes Dosage Information
- Glucophage (FDA)
Search Again
